Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Apr 21, 2020 8:04am

161 Views

Post# 30933063

RE:Quarterly Update is out.

Thanks Macer I really didn't expect this to take 6 months but here we are and I hope this clears us the path to open into US trials.

Theralase has submitted to it’s Clinical Hold Complete

Response to the FDA. The Company’s response has

addressed all deficiencies identified in the November 25,

2019 letter from the FDA that placed the Investigation New

Drug (“IND”) application on Full Clinical Hold pending

resolution of specific deficiencies identified in the letter. A

response is expected from the FDA on or about mid May

2020

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario